Volume 12, Issue 3 (Vol.12 No.3 Oct 2023)                   rbmb.net 2023, 12(3): 487-494 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abdi Pastaki M, Salimi S, Heidari Z, Saravani M. An Association Between GAS5 rs145204276, NEAT1 rs512715, and MEG3 rs4081134 Gene Polymorphisms and Papillary Thyroid Carcinoma. rbmb.net 2023; 12 (3) :487-494
URL: http://rbmb.net/article-1-1200-en.html
Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran & Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran.
Abstract:   (807 Views)
Background: This study explores the association between growth arrest-specific 5 (GAS5) rs145204276, nuclear paraspeckle assembly transcript 1 (NEAT1) rs512715, and Maternally Expressed 3 (MEG3) rs4081134 polymorphisms and their impact on susceptibility to papillary thyroid carcinoma (PTC), considering differential expression of long noncoding RNAs (lncRNAs) in PTC.

Methods: A case-control study involving 125 papillary thyroid carcinoma (PTC) patients and 125 controls was conducted. Genotyping of polymorphisms was performed using tetra-primer amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP) methods.

Results: No significant association was found between the two groups regarding genotypes and allelic frequencies of GAS-5 145204276 and MEG3 rs4081134 polymorphisms. Genetic models also showed the same results. Regarding NEAT1 rs512715, The PTC group had more GC genotypes and over-dominant models of NEAT1 rs512715 than controls, while controls showed a higher frequency of recessive models.

Conclusion: GAS5 rs145204276 and MEG3 rs4081134 polymorphisms showed no significant association with papillary thyroid carcinoma (PTC) risk. In contrast, NEAT1 rs512715 exhibited a significant impact on PTC development.
 
Full-Text [PDF 211 kb]   (305 Downloads)    
Type of Article: Original Article | Subject: Molecular Biology
Received: 2023/06/28 | Accepted: 2023/12/2 | Published: 2024/02/25

References
1. Carling T, Udelsman R. Thyroid cancer. Annu Rev Med. 2014; 65:125-37. [DOI:10.1146/annurev-med-061512-105739] [PMID]
2. Saljooghi S, Heidari Z, Saravani M, Rezaei M, Salimi S. Association of FOXO1 Rs17592236 Polymorphism and Tumor Size in Papillary Thyroid Carcinoma. Rep Biochem Mol Biol. 2022;11(2):216-23.
3. Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783-95. [DOI:10.1016/S0140-6736(16)30172-6] [PMID]
4. Mattick JS, Makunin IV. Small regulatory RNAs in mammals. Hum Mol Genet. 2005;14 (1):R121-32. [DOI:10.1093/hmg/ddi101] [PMID]
5. Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Front Genet. 2012;3:219. [DOI:10.3389/fgene.2012.00219] [PMID] []
6. Beiramzadeh A, Heidari Z, Norouzi M, Saravani M. Association Between HOTAIR rs920778 and H19 rs3741219 Polymorphisms with Hashimoto's Thyroiditis (HT) and Graves' Disease (GD). Rep Biochem Mol Biol. 2022;11(3):377-85. [DOI:10.52547/rbmb.11.3.377] [PMID] []
7. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703-19. [DOI:10.4161/rna.20481] [PMID] []
8. Yang M, Tian J, Guo X, Yang Y, Guan R, Qiu M, Li Y, et al. Long noncoding RNA are aberrantly expressed in human papillary thyroid carcinoma. Oncol Lett. 2016;12(1):544-552. [DOI:10.3892/ol.2016.4653] [PMID] []
9. Smith CM, Steitz JA. Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol. 1998;18(12):6897-909. [DOI:10.1128/MCB.18.12.6897] [PMID] []
10. Lu X, Fang Y, Wang Z, Xie J, Zhan Q, Deng X, et al. Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6. Cell Tissue Res. 2013;354(3):891-6. [DOI:10.1007/s00441-013-1711-x] [PMID]
11. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28(2):195-208. [DOI:10.1038/onc.2008.373] [PMID]
12. Yin D, He X, Zhang E, Kong R, De W, Zhang Z. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31(11):253. [DOI:10.1007/s12032-014-0253-8] [PMID]
13. Guo C, Song WQ, Sun P, Jin L, Dai HY. LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci. 2015; 22:100. [DOI:10.1186/s12929-015-0213-4] [PMID] []
14. Liu Z, Wang W, Jiang J, Bao E, Xu D, Zeng Y, et al. Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6. PLoS One. 2013;8(9): e73991. [DOI:10.1371/journal.pone.0073991] [PMID] []
15. Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014; 14:319. [DOI:10.1186/1471-2407-14-319] [PMID] []
16. Xu Y, Lu J, Lou N, Lu W, Xu J, Jiang H, et al. Noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN/STAT1 signaling pathway. Pathol Res Pract. 2022; 233:153856. [DOI:10.1016/j.prp.2022.153856] [PMID]
17. Zhang XF, Ye Y, Zhao SJ. LncRNA Gas5 acts as a ceRNA to regulate PTEN expression by sponging miR-222-3p in papillary thyroid carcinoma. Oncotarget. 2018;9(3):3519-30. [DOI:10.18632/oncotarget.23336] [PMID] []
18. Dong P, Xiong Y, Yue J, Hanley SJB, Kobayashi N, Todo Y, et al. Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors. Front Genet. 2018; 9:471. [DOI:10.3389/fgene.2018.00471] [PMID] []
19. Sun W, Lan X, Zhang H, Wang Z, Dong W, He L, et al. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid carcinoma. Cell Death Dis. 2018;9(3):380. [DOI:10.1038/s41419-018-0418-z] [PMID] []
20. Ghafouri-Fard S, Taheri M. Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA. Biomed Pharmacother. 2019;118:109129. [DOI:10.1016/j.biopha.2019.109129] [PMID]
21. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. 2010;70(6):2350-8. [DOI:10.1158/0008-5472.CAN-09-3885] [PMID] []
22. Wang C, Yan G, Zhang Y, Jia X, Bu P. Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1. Neoplasma. 2015;62(4):541-9. [DOI:10.4149/neo_2015_065] [PMID]
23. Messemaker TC, Frank-Bertoncelj M, Marques RB, Adriaans A, Bakker AM, Daha N, et al. A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels. Genes Immun. 2016;17(2):85-92. [DOI:10.1038/gene.2015.54] [PMID]
24. Sharifi R, Shahangian SS, Salehi Z, Mashayekhi F, Talesh Sasani S, Mirzanezhad L. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer. Asian Pac J Cancer Prev. 2020;21(12):3705-3710. [DOI:10.31557/APJCP.2020.21.12.3705] [PMID] []
25. Xiao X, Li L, Cui JC, Wang Y. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(8):4361-4367.
26. Wang Y, Gu J, Lin X, Yan W, Yang W, Wu G. lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway. Oncol Lett. 2018;15(4):5865-70. [DOI:10.3892/ol.2018.8017] [PMID] []
27. Yang X, Xie Z, Lei X, Gan R. Long non-coding RNA GAS5 in human cancer. Oncol Lett. 2020;20(3):2587-94. [DOI:10.3892/ol.2020.11809] [PMID] []
28. Guo L-J, Zhang S, Gao B, Jiang Y, Zhang X-H, Tian W-G, et al. Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer. 2017;102(3):500-4. [DOI:10.1016/j.yexmp.2017.05.008] [PMID]
29. Xiang X, Chen L, He J, Ma G, Li Y. LncRNA GAS5 rs145204276 Polymorphism Reduces Renal Cell Carcinoma Susceptibility in Southern Chinese Population. J Inflamm Res. 2022;15:1147-1158. [DOI:10.2147/JIR.S348628] [PMID] []
30. Li Q, Ma G, Sun S, Xu Y, Wang B. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer. Clin Res Hepatol Gastroenterol. 2018;42(5):478-482. [DOI:10.1016/j.clinre.2018.01.006] [PMID]
31. Tao R, Hu S, Wang S, Zhou X, Zhang Q, Wang C, et al. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Carcinogenesis. 2015;36(10):1136-43. [DOI:10.1093/carcin/bgv099] [PMID]
32. Liu Y, Yue P, Zhou T, Zhang F, Wang H, Chen X. LncRNA MEG3 enhances 131I sensitivity in thyroid carcinoma via sponging miR-182. Biomed Pharmacother. 2018;105:1232-1239. [DOI:10.1016/j.biopha.2018.06.087] [PMID]
33. Pei JS, Chang WS, Chen CC, Mong MC, Hsu SW, Hsu PC, et al. Novel Contribution of Long Non-coding RNA MEG3 Genotype to Prediction of Childhood Leukemia Risk. Cancer Genomics Proteomics. 2022;19(1):27-34. [DOI:10.21873/cgp.20301] [PMID] []
34. Zhuo ZJ, Zhang R, Zhang J, Zhu J, Yang T, Zou Y, et al. Associations between lncRNA MEG3 polymorphisms and neuroblastoma risk in Chinese children. Aging (Albany NY). 2018;10(3):481-491. [DOI:10.18632/aging.101406] [PMID] []
35. Yang Z, Li H, Li J, Lv X, Gao M, Bi Y, et al. Association Between Long Noncoding RNA MEG3 Polymorphisms and Lung Cancer Susceptibility in Chinese Northeast Population. DNA Cell Biol. 2018;37(10):812-20. [DOI:10.1089/dna.2018.4277] [PMID]
36. Zhang H, Cai Y, Zheng L, Zhang Z, Lin X, Jiang N. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. J Cell Physiol. 2018;233(10):6638-6648. [DOI:10.1002/jcp.26425] [PMID]
37. Sun W, Lan X, Zhang H, Wang Z, Dong W, He L, et al. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer. Cell Death Dis. 2018;9(3):380. [DOI:10.1038/s41419-018-0418-z] [PMID] []
38. Wang S, Cui Z, Li H, Li J, Lv X, Yang Z, et al. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study. Pathol Res Pract. 2019;215(12):152723. [DOI:10.1016/j.prp.2019.152723] [PMID]
39. Fang J, Li Y, Zhang J, Yan M, Li J, Bao S, et al. Correlation between polymorphisms in microRNA-regulated genes and cervical cancer susceptibility in a Xinjiang Uygur population. Oncotarget. 2017;8(19):31758-64. [DOI:10.18632/oncotarget.15970] [PMID] []

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Reports of Biochemistry and Molecular Biology

Designed & Developed by : Yektaweb